The latest updated of drug registration lists on 03 May 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
301 DIAMIDE 5 MG/ 500 MG GLIBENCLAMIDE 5 MG METFORMIN HYDROCHLORIDE 500 MG FILM-COATED TABLETS BLISTERPACK AS SECOND LINE THERAPY WHEN DIET, EXCERCISE AND INITIAL TREATMENT WITH A SULFONYLUREA OR METFORMIN DO NOT RESULT IN ADEQUEATE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES. No BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 09 I 4172/16 2023-06-07 2026-06-06 View
302 DIFLUVID FLUCONAZOLE 150 MG CAPSULE BLISTERPACK - MUCOSAL CANDIDIASIS. THESE INCLUDE OROPHARYNGEAL, ESOPHAGEAL, NON INVASIVE BRONCHOPULMONARY INFECTIONS, CANDIDURIA, - GENITAL CANDIDIASIS : VAGINAL CANDIDIASIS, ACUTE OR RECURRENT AND PROPHYLAXIS TO REDUCE THE INCIDENCE OF RECURRENT VAGINAL CANDIDIASIS Yes BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 02 I 4211/17 2023-06-07 2026-06-06 View
303 DISUF-B CREAM ANYDROUS FUSIDIC ACID 2% W/W, BETAMETHASONE VALERATE EQ.TO BETAMETHASONE 0.1% W/W CREAM TUBE IN INFLAMMATORY DERMATOSES WHERE BACTERIAL INFECTION IS PRESENT OR LIKELY TO OCCUR. INFLAMMATORY DERMATOSESE INCLUDE ATOPIC ECZEMA, DISCOID ECZEMA, STASIS ECZEMA, SEBORRHEIC DERMATITIS, CONTACT DERMATITIS, LICHEN SIMPLEX CHRONICUS, PSORIASIS, DISCOID LUPUS ERYTHEMATOSUS No BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 08 I 5272/22 2022-08-26 2025-08-25 View
304 DISUF-H CREAM FUSIDIC ACID 2 %W/W, HYDROCORTISONE ACETATE 1% W/W CREAM TUBE FOR THE TREATMENT OF DERMATITIS, INCLUDING ATOPIC DERMATITIS AND CONTACT DERMATITIS, WHERE AN INFECTION WITH BACTERIA SENSITIVE TO FUSIDIC ACID IS SUSPECTED OR CONFIRMED No BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 06 I 5538/23 2023-06-26 2026-06-25 View
305 DOXYCAP DOXYCYCLINE HYDROCHLORIDE/HYCLATE 100 MG CAPSULE BLISTERPACK RICKETTSIAL INFECTIONS, INCLUDING TYPHUS, ROCKY MOUNTAIN SPOTTED FEVER AND Q FEVER. CHLAMYDIAL INFECTIONS, INCLUDING PSITTACOSIS. MYCOPLASMA INFECTIONS, BRUCELLOSIS AND PLAGUE. TULARAEMIA, CHRONIC BRONCHITIS. CHOLERA, RELAPSING FEVER, LEPTOSPIROSIS AND EARLY STAGE OF LYME DISEASE, BALANTIDIASIS, AMOEBIC DYSENTERY. SYPHILIS, YAWS, GONORRHEA, ACTINOMYCOSIS, ANTHRAX. Yes BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 04 I 4687/19 2022-09-08 2025-09-07 View
306 EROGRAN GRANULES ERYTHOMYCIN ETHYLSUCCINATE EQ.TO ERYTHOMYCIN 200 MG/5 ML GRANULES FOR SUSPENSION BOTTLE IN THE TREATMENT OR PROPHYLAXIS OF THE FOLLOWING: UPPER AND LOWER RESPIRATORY TRACT INFECTIONS, SKIN AND SOFT TISSUE INFECTION INCLUDING GONORRHEA AND SYPHILLIS, INTESTINAL AMOEBIASIS, OTHER INCLUDE BACTERIAL ENDOCARDITIS, TREPTOCOCCAL PHAYNGITIS, DIPHTHERIA, LEGIONNAIRES'S DISEASE AND PERTUSSIA Yes BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 08 I 5273/22 2022-08-26 2025-08-25 View
307 FELXICAM PIROXICAM 20 MG CAPSULE BLISTERPACK FOR THE SYMPTOMATIC RELIEF OF PAIN AND IN PATIENTS WITH OSTEOARTHRITIS, RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS. No BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 07 I 4172/16 2023-06-07 2026-06-06 View
308 FLOVID 200 OFLOXACIN 200 MG TABLET BLISTERPACK FOR THE TREATMENT OF UPPER AND LOWER URINARY TRACT INFECTIONS, LOWER RESPIRATORY TRACT INFECTIONS, UNCOMPLICATED URETHRAL AND CERVICAL GONORRHOEA. NON GONOCOCCAL URETHRITIS AND CERVICITIS, SKIN AND SOFT TISSUE INFECTIONS Yes BMS PHARMA SOLE CO.,LTD HOVID BHD MALAYSIA CERTIFICATE RELEASED 06 I 4040/15 2022-05-30 2025-05-29 View
309 GASCOVID ADVANCE LIQUID EACH 10 ML CONTAINS: SODIUM ALGINATE 1000 MG, POTASSIUM BICARBONATE 200 MG LIQUID BOTTLE TREATMENT OF SYMPTOMS OF GASTRO-OESOPHAGEAL REFLUX SUCH AS ACID REGURGITATION, HEARTBURN, INDIGESTION OCCURRING TO THE REFLUX OF STOMACH CONTENTS, FOR INSTANCE, AFTER GASTRIC SURGERY, AS A RESULT OF HIATUS HERNIA, DURING PREGNANCY OR ACCOMPANYING REFLUX OESOPHAGITIS. No BMS PHARMA SOLE CO.,LTD HOVID BERHAD MALAYSIA CERTIFICATE RELEASED 08 I 5586/23 2023-08-02 2026-08-01 View
310 GASCOVID LIQUID EACH 10 ML CONTAINS: SODIUM ALGINATE 500 MG, SODIUM BICARBONATE 267 MG, CALCIUM CARBONATE 160 MG LIQUID BOTTLE TREATMENT OF SYMPTOMS OF GASTRO-OESOPHAGEAL REFLUX SUCH AS ACID REGURGITATION, HEARTBURN, INDIGESTION DUE TO REFLUX OF STOMACH CONTENTS No BMS PHARMA SOLE CO.,LTD HOVID BERHAD MALAYSIA CERTIFICATE RELEASED 08 I 5585/23 2023-08-02 2026-08-01 View